Endonovo Therapeutics Income Statement (2010-2023) | ENDV

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2010 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023
Revenue & cost
Revenue (Quarter) 0.00M0.01M0.01M0.01M0.02M0.00M0.00M400.000.01M0.01M0.02M0.04M0.04M0.06M0.05M0.15M0.07M0.04M0.04M0.01M0.03M0.03M0.01M316.000.00M650.000.01M0.12M0.09M0.05M0.00M
Cost of Revenue (Quarter) 0.01M824.000.00M550.000.00M0.01M0.01M0.03M0.01M0.05M0.01M0.01M760.000.05M0.00M500.000.00M0.01M714.00383.000.00M0.00M0.00M827.00
Gross Profit (Quarter) 0.01M0.00M582.00-400.000.01M0.01M0.02M0.03M0.04M0.03M0.05M0.10M0.06M0.03M0.04M-0.04M0.03M0.03M0.00M-0.01M0.00M267.000.01M0.12M0.08M0.05M693.00
Operating items
Other Operating Expenses (Quarter) 0.43M0.40M0.38M0.56M1.03M0.58M0.43M0.49M0.47M1.25M1.40M2.07M1.31M1.28M0.83M1.05M1.07M0.85M1.01M1.34M0.83M0.74M0.64M0.99M0.65M0.62M0.60M0.70M0.37M0.49M1.80M0.50M0.60M0.61M1.18M0.47M
Operating Expenses (Quarter) 0.55M0.43M0.40M0.38M0.56M1.03M0.58M0.43M0.49M0.47M1.25M1.40M2.07M1.31M1.28M0.83M1.05M1.07M0.85M1.01M1.34M0.83M0.74M0.64M0.99M0.65M0.62M0.60M0.70M0.37M0.49M1.80M0.50M0.60M0.61M1.18M0.47M
Operating Income (Quarter) -0.03M-0.43M-0.40M-0.37M-0.55M-1.03M-0.57M-0.43M-0.49M-0.47M-1.25M-1.40M-2.07M-1.31M-1.28M-0.82M-1.04M-1.03M-0.81M-0.97M-1.29M-0.73M-0.68M-0.60M-0.95M29.13M-0.59M-0.57M-0.69M-0.37M-0.49M-1.80M-0.50M35.78M-0.53M-1.13M-0.47M
EBIT (Quarter) -0.03M-0.43M-0.40M-0.37M-0.55M-1.03M-0.57M-0.43M-0.49M-0.47M-1.25M-1.40M-2.07M-1.31M-1.28M-0.82M-1.04M-1.03M-0.81M-0.97M-1.29M-0.73M-0.68M-0.60M-0.95M29.13M-0.59M-0.57M-0.69M-0.37M-0.49M-1.80M-0.50M35.78M-0.53M-1.13M-0.47M
Non-operating items
Interest & Investment Income (Quarter) 7.00-0.03M-0.02M
Other Non Operating Income (Quarter) 535.00-0.05M0.03M-0.81M0.13M0.50M1.57M-0.91M0.66M-0.43M0.05M2.30M-0.01M-5.47M0.01M-7.55M6.46M-0.86M0.42M5.67M-1.70M0.11M-0.04M-0.01M-1.53M0.10M0.32M-13.82M0.05M-0.02M
Non Operating Income (Quarter) -0.06M-0.05M-0.06M-0.81M-3.28M0.50M0.61M-0.91M0.66M-0.43M-4.91M2.41M-1.59M-6.86M-0.11M-4.93M5.02M-1.03M-0.12M-1.35M-2.09M-0.73M-0.83M2.77M-1.93M-0.18M-0.03M-15.00M-0.01M-0.02M-0.29M
Net income details
EBT (Quarter) -0.53M-0.43M-0.43M-0.39M-0.51M-1.13M-0.63M-0.48M-0.56M-1.28M-4.53M-0.90M-1.45M-2.22M-0.62M-1.25M-5.95M1.38M-2.41M-7.84M-1.41M-5.66M4.34M-1.63M-1.07M-2.03M-2.68M-1.30M-1.52M2.40M-2.41M-2.53M-0.60M-12.93M7.23M2.06M-0.77M
Tax Provisions (Quarter) 533.00
Profit After Tax (Quarter) -0.55M-0.43M-0.43M-0.39M-0.51M-1.13M-0.63M-0.48M-0.56M-1.28M-4.53M-0.90M-1.45M-2.22M-0.62M-1.25M-5.95M1.38M-2.41M-7.84M-1.41M-5.66M4.34M-1.63M-1.07M-2.03M-2.68M-1.30M-1.52M2.40M-2.41M-2.53M-0.60M-12.93M7.23M2.06M-0.77M
Income from Continuing Operations (Quarter) -0.53M-0.43M-0.43M-0.39M-0.51M-1.13M-0.63M-0.48M-0.56M-1.28M-4.53M-0.90M-1.45M-2.22M-0.62M-1.25M-5.95M1.38M-2.41M-7.84M-1.41M-5.66M4.34M-1.63M-1.07M-2.03M-2.68M-1.30M-1.52M2.40M-2.41M-2.53M-0.60M-12.93M7.23M2.06M-0.77M
Consolidated Net Income (Quarter) -0.53M-0.43M-0.43M-0.39M-0.51M-1.13M-0.63M-0.48M-0.56M-1.28M-4.53M-0.90M-1.45M-2.22M-0.62M-1.25M-5.95M1.38M-2.41M-7.84M-1.41M-5.66M4.34M-1.63M-1.07M-2.03M-2.68M-1.30M-1.52M2.40M-2.41M-2.53M-0.60M-12.93M7.23M2.06M-0.77M
Income towards Parent Company (Quarter) -0.53M-0.43M-0.43M-0.39M-0.51M-1.13M-0.63M-0.48M-0.56M-1.28M-4.53M-0.90M-1.45M-2.22M-0.62M-1.25M-5.95M1.38M-2.41M-7.84M-1.41M-5.66M4.34M-1.63M-1.07M-2.03M-2.68M-1.30M-1.52M2.40M-2.41M-2.53M-0.60M-12.93M7.23M2.06M-0.77M
Net Income towards Common Stockholders (Quarter) -0.53M-0.43M-0.43M-0.39M-0.51M-1.13M-0.63M-0.48M-0.56M-1.28M-4.53M-0.90M-1.45M-2.22M-0.62M-1.25M-5.95M1.38M-2.41M-7.84M-1.41M-5.66M4.34M-1.63M-1.07M-2.03M-2.68M-1.30M-1.52M2.40M-10.24M-2.53M-0.60M-12.93M-0.50M2.06M-0.48M
Additional items
EPS (Basic) (Quarter) -0.01-0.01-0.01-0.01-0.01-0.02-0.01-0.01-3.93-0.010.260.07-0.01-0.01-0.01-0.05-0.01-0.01-0.020.000.00-0.02-17.74-4.99-13.57-1.81-5.831.47-0.17-0.07-0.20-0.06-0.02-0.020.05-0.03-0.020.00-0.080.030.010.00
EPS (Weighted Average and Diluted) (Quarter) -0.010.00-4.99-13.57-1.81-0.14-0.17-0.07-0.06-0.02-0.02-0.03-0.020.000.00-0.010.00
Shares Outstanding (Weighted Average) (Quarter) 4.53M36.93M40.47M21.23M51.15M48.14M47.10M63.80M73.06M0.73M86.00M0.83M45.39M30.29M84.82M91.36M94.65M96.84M106.57M108.86M123.14M327.51M347.94M369.23M0.36M0.48M0.53M0.61M0.70M2.95M6.37M16.14M12.22M41.57M50.08M66.29M59.84M79.01M134.36M122.54M139.21M251.36M263.95M276.36M
Shares Outstanding (Diluted Average) (Quarter) 108.86M347.94M0.48M0.53M0.78M11.93M9.83M23.58M41.57M50.08M66.29M79.01M134.36M122.54M1,743.12M1,338.36M1,350.81M
EBITDA (Quarter) -0.03M-0.43M-0.40M-0.37M-0.55M-1.03M-0.57M-0.43M-0.49M-0.47M-1.25M-1.40M-2.07M-1.31M-1.28M-0.82M-1.04M-1.03M-0.81M-0.97M-1.29M-0.73M-0.68M-0.60M-0.95M29.13M-0.59M-0.57M-0.69M-0.37M-0.49M-1.80M-0.50M35.78M-0.53M-1.13M-0.47M
Tax Rate (Quarter) -0.05%